Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

One potential solution is HIV self-testing, which would allow for rapid identification and treatment. Identifying HIV cases is the first step in addressing clusters, and quickly learning one’s ...

Priscilla Tsondai, MD, MPH, breaks down top care gaps as opportunities for care improvement.

When volunteers launched Pittsburgh Aids Task Force in 1985, they didn’t expect the organization would be operating 40 years later.

The pandemic stretched us—our communication, our science, our distribution networks, even what it means to be a good citizen ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term protection. If this yearly injection is approved and widely implemented ...

For decades, external actors, such as donors, funders, and implementing partners, have shaped Africa's HIV response. Although this strategy has saved millions of lives, it entrenched dependency, ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...